Cronos Group Inc. (NASDAQ:CRON – Get Free Report)’s stock price hit a new 52-week low during trading on Monday . The company traded as low as $1.61 and last traded at $1.62, with a volume of 221919 shares traded. The stock had previously closed at $1.71.
Cronos Group Stock Down 3.6 %
The company has a market capitalization of $619.70 million, a P/E ratio of -12.46, a price-to-earnings-growth ratio of 1.74 and a beta of 1.02. The business has a fifty day moving average price of $1.89 and a 200 day moving average price of $2.00.
Institutional Investors Weigh In On Cronos Group
Several hedge funds have recently added to or reduced their stakes in the business. Barclays PLC acquired a new stake in shares of Cronos Group in the third quarter valued at approximately $97,000. Janney Montgomery Scott LLC increased its holdings in shares of Cronos Group by 72.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company’s stock worth $769,000 after buying an additional 159,575 shares in the last quarter. Jones Financial Companies Lllp raised its position in Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company’s stock valued at $34,000 after purchasing an additional 6,520 shares during the last quarter. SBI Securities Co. Ltd. acquired a new position in shares of Cronos Group during the fourth quarter worth $30,000. Finally, WINTON GROUP Ltd grew its position in shares of Cronos Group by 106.5% in the 4th quarter. WINTON GROUP Ltd now owns 288,990 shares of the company’s stock valued at $584,000 after buying an additional 149,028 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company’s stock.
About Cronos Group
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Stories
- Five stocks we like better than Cronos Group
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Why Markets Suddenly See Opportunity in These Emerging Markets
- What Is WallStreetBets and What Stocks Are They Targeting?
- Amazon Stock Bounces From Lows as Smart Money Steps In
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Oil Prices Are Tanking—These 3 Plays Could Fuel Your Gains
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.